<DOC>
	<DOCNO>NCT02047201</DOCNO>
	<brief_summary>To evaluate safety efficacy cisplatin plus intensity-modulated radiotherapy ( IMRT ) base FDG-PET/CT induction chemotherapy ( IC ) locally advanced head neck squamous cell carcinoma .</brief_summary>
	<brief_title>Assessing Tumor Response IMRT Treat Plan After IC Based FDG-PET/CT Locally Advanced HNSCC</brief_title>
	<detailed_description>Current guideline define pre-IC target volume must use radiotherapy ( RT ) planning . This prospective , phase II trial assess result patient locally advance squamous cell carcinoma head neck treatment IC follow chemoradiotherapy ( CRT ) , use post-IC PET/CT image IMRT planning .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Male female patient age 18 year ; Histologically confirm locally advance ( stage III IV ) head neck squamous cell carcinoma ( HNSCC ) ; Eastern Cooperative Oncology Group ( ECOG ) performance status 0 1 ; Signed write informed consent approve Lithuanian Bioethics Committee ( LBEC ) ; Positive serum pregnancy test woman childbearing potential breastfeeding ; Presence distant metastasis ; Second primary tumor ; History malignancy within last 5 year ; Recurrent head neck cancer ; Serious uncontrolled concomitant disease would contraindicate use drug use study chemotherapy radiotherapy ; ; Inadequate organ function , evidence follow laboratory result : 1 . Absolute neutrophil count &lt; 1,500 cells/mm3 ; 2 . Platelet count &lt; 100,000 cells/mm3 ; 3 . Hemoglobin &lt; 9 g/dL ; 4 . Total bilirubin great upper limit normal ( ULN ) ; 5 . AST ( SGOT ) ALT ( SGPT ) &gt; 1,5 x ULN ; 6 . Alkaline phosphatase level &gt; 2,5 x ULN ; 7 . Serum creatinine &gt; 2,0 mg/dl 177 umol/l .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Head neck cancer</keyword>
	<keyword>PET/CT</keyword>
	<keyword>induction chemotherapy</keyword>
	<keyword>IMRT</keyword>
</DOC>